(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Downregulation of vimentin in C2C12 myotubes and biochemically differentiated cells. (A) Disappearance of vimentin filaments during terminal differentiation. Phase-contrast images (a,c) and corresponding immunofluorescent images detecting vimentin (b,d) in C2C12 myoblasts (a,b) and myotubes (c,d). (B) A decrease in vimentin (a) and an increase in desmin (b) during terminal differentiation detected by immunoblotting. (C) Disappearance of vimentin filaments in biochemically differentiated mononucleated cells. Phase-contrast images (a,c) and corresponding immunofluorescent images detecting vimentin (b,d) of sodium butyrate-treated (a,b) or DMSO-treated (c,d) C2C12 cells. Cells were treated as described for Fig. 2B. Arrows indicate a biochemically differentiated cell, which has a invaginated nucleus and a markedly reduced number of vimentin filaments (c,d). Bar, 20 µm.